APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Drug Contaminants Detection and Analysis

Compare research editions
View pricing & licenses

Selected research

Industry Research

Drug Contaminants Detection and Analysis Industry Research Report 2026

Report ID 17412309053 June 2026142 pages

Choose your research edition.

Industry ResearchDrug Contaminants Detection and Analysis Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug Contaminants Detection and Analysis Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Drug Contaminants Detection and Analysis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug Contaminants Detection and Analysis Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug Contaminants Detection and Analysis Market Analysis and Forecast 2026-2032250 pages · $4,950 USD

Market perspective

The global Drug Contaminants Detection and Analysis market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Drug Contaminants Detection and Analysis market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Drug Contaminants Detection and Analysis market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Drug Contaminants Detection and Analysis market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Drug Contaminants Detection and Analysis include Eurofins Scientific (Luxembourg), SGS (Switzerland), Intertek (UK), Thermo Fisher Scientific (USA), Charles River Laboratories (USA), Labcorp Biopharma (USA), WuXi STA / WuXi AppTec (China), Cambrex (USA) and Pharmaron (China), among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Drug Contaminants Detection and Analysis market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Drug Contaminants Detection and Analysis.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Drug Contaminants Detection and Analysis Market by Company

Eurofins Scientific (Luxembourg)

SGS (Switzerland)

Intertek (UK)

Thermo Fisher Scientific (USA)

Charles River Laboratories (USA)

Labcorp Biopharma (USA)

WuXi STA / WuXi AppTec (China)

Cambrex (USA)

Pharmaron (China)

Piramal Pharma Solutions (India)

Syngene (India)

Recipharm (Sweden)

Almac Sciences (UK)

MedPharm (UK)

CMIC (Japan)

Aenova (Germany)

Sterling Pharma Solutions (UK)

Curia (USA)

Ardena (Belgium)

Hovione (Portugal)

Delpharm (France)

AGC Biologics (USA)

FUJIFILM Biotechnologies (Japan)

KBI Biopharma (USA)

Rentschler Biopharma (Germany)

Ajinomoto Bio-Pharma Services (Japan)

Bora Pharmaceuticals (Taiwan, China)

Kindeva (USA)

CordenPharma (Switzerland)

RSSL (UK)

Tentamus (Germany)

Element Materials Technology (UK)

Nucro-Technics (Canada)

ALS (Australia)

Aizant (India)

Wickham Laboratories (UK)

Toxikon (USA)

Evotec (Germany)

Drug Contaminants Detection and Analysis Segment by Type

Organic Pollutant Detection Products

Inorganic Pollutant Detection Products

Others

Drug Contaminants Detection and Analysis Segment by Application

Chemical Pharmaceutical Industry

Biopharmaceutical Industry

Traditional Chinese Medicine and Natural Medicine Industry

Others

Drug Contaminants Detection and Analysis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Contaminants Detection and Analysis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Contaminants Detection and Analysis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Contaminants Detection and Analysis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Drug Contaminants Detection and Analysis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Drug Contaminants Detection and Analysis Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Drug Contaminants Detection and Analysis Revenue Market Share by Type (2021-2026) Table 7. Global Drug Contaminants Detection and Analysis Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Drug Contaminants Detection and Analysis Revenue Market Share by Type (2027-2032) Table 9. Global Drug Contaminants Detection and Analysis Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Drug Contaminants Detection and Analysis Revenue Market Share by Application (2021-2026) Table 11. Global Drug Contaminants Detection and Analysis Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Drug Contaminants Detection and Analysis Revenue Market Share by Application (2027-2032) Table 13. Global Drug Contaminants Detection and Analysis Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Drug Contaminants Detection and Analysis Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Drug Contaminants Detection and Analysis Market Share by Region (2021-2026) Table 16. Global Drug Contaminants Detection and Analysis Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Drug Contaminants Detection and Analysis Market Share by Region (2027-2032) Table 18. Drug Contaminants Detection and Analysis Industry Trends Table 19. Drug Contaminants Detection and Analysis Industry Drivers Table 20. Drug Contaminants Detection and Analysis Industry Opportunities and Challenges Table 21. Drug Contaminants Detection and Analysis Market Restraints Table 22. Global Top Drug Contaminants Detection and Analysis Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Drug Contaminants Detection and Analysis Revenue Market Share by Players (2021-2026) Table 24. Global Drug Contaminants Detection and Analysis Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Drug Contaminants Detection and Analysis, Headquarters and Area Served Table 26. Global Drug Contaminants Detection and Analysis Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Drug Contaminants Detection and Analysis by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Drug Contaminants Detection and Analysis Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Drug Contaminants Detection and Analysis Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Drug Contaminants Detection and Analysis Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Drug Contaminants Detection and Analysis Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Drug Contaminants Detection and Analysis Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Drug Contaminants Detection and Analysis Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Drug Contaminants Detection and Analysis Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Drug Contaminants Detection and Analysis Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Drug Contaminants Detection and Analysis Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Drug Contaminants Detection and Analysis Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Drug Contaminants Detection and Analysis Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Drug Contaminants Detection and Analysis Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Drug Contaminants Detection and Analysis Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Drug Contaminants Detection and Analysis Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Drug Contaminants Detection and Analysis Market Size by Country (2027-2032) & (US$ Million) Table 45. Eurofins Scientific (Luxembourg) Company Information Table 46. Eurofins Scientific (Luxembourg) Business Overview Table 47. Eurofins Scientific (Luxembourg) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026) & (US$ Million) Table 48. Eurofins Scientific (Luxembourg) Drug Contaminants Detection and Analysis Product Portfolio Table 49. Eurofins Scientific (Luxembourg) Recent Developments Table 50. SGS (Switzerland) Company Information Table 51. SGS (Switzerland) Business Overview Table 52. SGS (Switzerland) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026) & (US$ Million) Table 53. SGS (Switzerland) Drug Contaminants Detection and Analysis Product Portfolio Table 54. SGS (Switzerland) Recent Developments Table 55. Intertek (UK) Company Information Table 56. Intertek (UK) Business Overview Table 57. Intertek (UK) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026) & (US$ Million) Table 58. Intertek (UK) Drug Contaminants Detection and Analysis Product Portfolio Table 59. Intertek (UK) Recent Developments Table 60. Thermo Fisher Scientific (USA) Company Information Table 61. Thermo Fisher Scientific (USA) Business Overview Table 62. Thermo Fisher Scientific (USA) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026) & (US$ Million) Table 63. Thermo Fisher Scientific (USA) Drug Contaminants Detection and Analysis Product Portfolio Table 64. Thermo Fisher Scientific (USA) Recent Developments Table 65. Charles River Laboratories (USA) Company Information Table 66. Charles River Laboratories (USA) Business Overview Table 67. Charles River Laboratories (USA) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026) & (US$ Million) Table 68. Charles River Laboratories (USA) Drug Contaminants Detection and Analysis Product Portfolio Table 69. Charles River Laboratories (USA) Recent Developments Table 70. Labcorp Biopharma (USA) Company Information Table 71. Labcorp Biopharma (USA) Business Overview Table 72. Labcorp Biopharma (USA) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026) & (US$ Million) Table 73. Labcorp Biopharma (USA) Drug Contaminants Detection and Analysis Product Portfolio Table 74. Labcorp Biopharma (USA) Recent Developments Table 75. WuXi STA / WuXi AppTec (China) Company Information Table 76. WuXi STA / WuXi AppTec (China) Business Overview Table 77. WuXi STA / WuXi AppTec (China) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026) & (US$ Million) Table 78. WuXi STA / WuXi AppTec (China) Drug Contaminants Detection and Analysis Product Portfolio Table 79. WuXi STA / WuXi AppTec (China) Recent Developments Table 80. Cambrex (USA) Company Information Table 81. Cambrex (USA) Business Overview Table 82. Cambrex (USA) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026) & (US$ Million) Table 83. Cambrex (USA) Drug Contaminants Detection and Analysis Product Portfolio Table 84. Cambrex (USA) Recent Developments Table 85. Pharmaron (China) Company Information Table 86. Pharmaron (China) Business Overview Table 87. Pharmaron (China) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026) & (US$ Million) Table 88. Pharmaron (China) Drug Contaminants Detection and Analysis Product Portfolio Table 89. Pharmaron (China) Recent Developments Table 90. Piramal Pharma Solutions (India) Company Information Table 91. Piramal Pharma Solutions (India) Business Overview Table 92. Piramal Pharma Solutions (India) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026) & (US$ Million) Table 93. Piramal Pharma Solutions (India) Drug Contaminants Detection and Analysis Product Portfolio Table 94. Piramal Pharma Solutions (India) Recent Developments Table 95. Syngene (India) Company Information Table 96. Syngene (India) Business Overview Table 97. Syngene (India) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026) & (US$ Million) Table 98. Syngene (India) Drug Contaminants Detection and Analysis Product Portfolio Table 99. Syngene (India) Recent Developments Table 100. Recipharm (Sweden) Company Information Table 101. Recipharm (Sweden) Business Overview Table 102. Recipharm (Sweden) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026) & (US$ Million) Table 103. Recipharm (Sweden) Drug Contaminants Detection and Analysis Product Portfolio Table 104. Recipharm (Sweden) Recent Developments Table 105. Almac Sciences (UK) Company Information Table 106. Almac Sciences (UK) Business Overview Table 107. Almac Sciences (UK) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026) & (US$ Million) Table 108. Almac Sciences (UK) Drug Contaminants Detection and Analysis Product Portfolio Table 109. Almac Sciences (UK) Recent Developments Table 110. MedPharm (UK) Company Information Table 111. MedPharm (UK) Business Overview Table 112. MedPharm (UK) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026) & (US$ Million) Table 113. MedPharm (UK) Drug Contaminants Detection and Analysis Product Portfolio Table 114. MedPharm (UK) Recent Developments Table 115. CMIC (Japan) Company Information Table 116. CMIC (Japan) Business Overview Table 117. CMIC (Japan) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026) & (US$ Million) Table 118. CMIC (Japan) Drug Contaminants Detection and Analysis Product Portfolio Table 119. CMIC (Japan) Recent Developments Table 120. Aenova (Germany) Company Information Table 121. Aenova (Germany) Business Overview Table 122. Aenova (Germany) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026) & (US$ Million) Table 123. Aenova (Germany) Drug Contaminants Detection and Analysis Product Portfolio Table 124. Aenova (Germany) Recent Developments Table 125. Sterling Pharma Solutions (UK) Company Information Table 126. Sterling Pharma Solutions (UK) Business Overview Table 127. Sterling Pharma Solutions (UK) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026) & (US$ Million) Table 128. Sterling Pharma Solutions (UK) Drug Contaminants Detection and Analysis Product Portfolio Table 129. Sterling Pharma Solutions (UK) Recent Developments Table 130. Curia (USA) Company Information Table 131. Curia (USA) Business Overview Table 132. Curia (USA) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026) & (US$ Million) Table 133. Curia (USA) Drug Contaminants Detection and Analysis Product Portfolio Table 134. Curia (USA) Recent Developments Table 135. Ardena (Belgium) Company Information Table 136. Ardena (Belgium) Business Overview Table 137. Ardena (Belgium) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026) & (US$ Million) Table 138. Ardena (Belgium) Drug Contaminants Detection and Analysis Product Portfolio Table 139. Ardena (Belgium) Recent Developments Table 140. Hovione (Portugal) Company Information Table 141. Hovione (Portugal) Business Overview Table 142. Hovione (Portugal) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026) & (US$ Million) Table 143. Hovione (Portugal) Drug Contaminants Detection and Analysis Product Portfolio Table 144. Hovione (Portugal) Recent Developments Table 145. Delpharm (France) Company Information Table 146. Delpharm (France) Business Overview Table 147. Delpharm (France) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026) & (US$ Million) Table 148. Delpharm (France) Drug Contaminants Detection and Analysis Product Portfolio Table 149. Delpharm (France) Recent Developments Table 150. AGC Biologics (USA) Company Information Table 151. AGC Biologics (USA) Business Overview Table 152. AGC Biologics (USA) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026) & (US$ Million) Table 153. AGC Biologics (USA) Drug Contaminants Detection and Analysis Product Portfolio Table 154. AGC Biologics (USA) Recent Developments Table 155. FUJIFILM Biotechnologies (Japan) Company Information Table 156. FUJIFILM Biotechnologies (Japan) Business Overview Table 157. FUJIFILM Biotechnologies (Japan) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026) & (US$ Million) Table 158. FUJIFILM Biotechnologies (Japan) Drug Contaminants Detection and Analysis Product Portfolio Table 159. FUJIFILM Biotechnologies (Japan) Recent Developments Table 160. KBI Biopharma (USA) Company Information Table 161. KBI Biopharma (USA) Business Overview Table 162. KBI Biopharma (USA) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026) & (US$ Million) Table 163. KBI Biopharma (USA) Drug Contaminants Detection and Analysis Product Portfolio Table 164. KBI Biopharma (USA) Recent Developments Table 165. Rentschler Biopharma (Germany) Company Information Table 166. Rentschler Biopharma (Germany) Business Overview Table 167. Rentschler Biopharma (Germany) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026) & (US$ Million) Table 168. Rentschler Biopharma (Germany) Drug Contaminants Detection and Analysis Product Portfolio Table 169. Rentschler Biopharma (Germany) Recent Developments Table 170. Ajinomoto Bio-Pharma Services (Japan) Company Information Table 171. Ajinomoto Bio-Pharma Services (Japan) Business Overview Table 172. Ajinomoto Bio-Pharma Services (Japan) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026) & (US$ Million) Table 173. Ajinomoto Bio-Pharma Services (Japan) Drug Contaminants Detection and Analysis Product Portfolio Table 174. Ajinomoto Bio-Pharma Services (Japan) Recent Developments Table 175. Bora Pharmaceuticals (Taiwan, China) Company Information Table 176. Bora Pharmaceuticals (Taiwan, China) Business Overview Table 177. Bora Pharmaceuticals (Taiwan, China) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026) & (US$ Million) Table 178. Bora Pharmaceuticals (Taiwan, China) Drug Contaminants Detection and Analysis Product Portfolio Table 179. Bora Pharmaceuticals (Taiwan, China) Recent Developments Table 180. Kindeva (USA) Company Information Table 181. Kindeva (USA) Business Overview Table 182. Kindeva (USA) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026) & (US$ Million) Table 183. Kindeva (USA) Drug Contaminants Detection and Analysis Product Portfolio Table 184. Kindeva (USA) Recent Developments Table 185. CordenPharma (Switzerland) Company Information Table 186. CordenPharma (Switzerland) Business Overview Table 187. CordenPharma (Switzerland) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026) & (US$ Million) Table 188. CordenPharma (Switzerland) Drug Contaminants Detection and Analysis Product Portfolio Table 189. CordenPharma (Switzerland) Recent Developments Table 190. RSSL (UK) Company Information Table 191. RSSL (UK) Business Overview Table 192. RSSL (UK) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026) & (US$ Million) Table 193. RSSL (UK) Drug Contaminants Detection and Analysis Product Portfolio Table 194. RSSL (UK) Recent Developments Table 195. Tentamus (Germany) Company Information Table 196. Tentamus (Germany) Business Overview Table 197. Tentamus (Germany) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026) & (US$ Million) Table 198. Tentamus (Germany) Drug Contaminants Detection and Analysis Product Portfolio Table 199. Tentamus (Germany) Recent Developments Table 200. Element Materials Technology (UK) Company Information Table 201. Element Materials Technology (UK) Business Overview Table 202. Element Materials Technology (UK) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026) & (US$ Million) Table 203. Element Materials Technology (UK) Drug Contaminants Detection and Analysis Product Portfolio Table 204. Element Materials Technology (UK) Recent Developments Table 205. Nucro-Technics (Canada) Company Information Table 206. Nucro-Technics (Canada) Business Overview Table 207. Nucro-Technics (Canada) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026) & (US$ Million) Table 208. Nucro-Technics (Canada) Drug Contaminants Detection and Analysis Product Portfolio Table 209. Nucro-Technics (Canada) Recent Developments Table 210. ALS (Australia) Company Information Table 211. ALS (Australia) Business Overview Table 212. ALS (Australia) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026) & (US$ Million) Table 213. ALS (Australia) Drug Contaminants Detection and Analysis Product Portfolio Table 214. ALS (Australia) Recent Developments Table 215. Aizant (India) Company Information Table 216. Aizant (India) Business Overview Table 217. Aizant (India) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026) & (US$ Million) Table 218. Aizant (India) Drug Contaminants Detection and Analysis Product Portfolio Table 219. Aizant (India) Recent Developments Table 220. Wickham Laboratories (UK) Company Information Table 221. Wickham Laboratories (UK) Business Overview Table 222. Wickham Laboratories (UK) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026) & (US$ Million) Table 223. Wickham Laboratories (UK) Drug Contaminants Detection and Analysis Product Portfolio Table 224. Wickham Laboratories (UK) Recent Developments Table 225. Toxikon (USA) Company Information Table 226. Toxikon (USA) Business Overview Table 227. Toxikon (USA) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026) & (US$ Million) Table 228. Toxikon (USA) Drug Contaminants Detection and Analysis Product Portfolio Table 229. Toxikon (USA) Recent Developments Table 230. Evotec (Germany) Company Information Table 231. Evotec (Germany) Business Overview Table 232. Evotec (Germany) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026) & (US$ Million) Table 233. Evotec (Germany) Drug Contaminants Detection and Analysis Product Portfolio Table 234. Evotec (Germany) Recent Developments Table 235. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Drug Contaminants Detection and Analysis Product Image Figure 5. Global Drug Contaminants Detection and Analysis Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Drug Contaminants Detection and Analysis Market Share by Type: 2025 VS 2032 Figure 7. Organic Pollutant Detection Products Product Figure 8. Inorganic Pollutant Detection Products Product Figure 9. Others Product Figure 10. Global Drug Contaminants Detection and Analysis Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Drug Contaminants Detection and Analysis Market Share by Application: 2025 VS 2032 Figure 12. Chemical Pharmaceutical Industry Product Figure 13. Biopharmaceutical Industry Product Figure 14. Traditional Chinese Medicine and Natural Medicine Industry Product Figure 15. Others Product Figure 16. Global Drug Contaminants Detection and Analysis Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 17. Global Drug Contaminants Detection and Analysis Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Drug Contaminants Detection and Analysis Market Share by Region: 2025 VS 2032 Figure 19. Global Drug Contaminants Detection and Analysis Market Share by Players in 2025 Figure 20. Global Drug Contaminants Detection and Analysis Manufacturers Established Date Figure 21. Global Top 5 and 10 Drug Contaminants Detection and Analysis Players Market Share by Revenue in 2025 Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. North America Drug Contaminants Detection and Analysis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Drug Contaminants Detection and Analysis Market Share by Country (2021-2032) Figure 25. United States Drug Contaminants Detection and Analysis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. Canada Drug Contaminants Detection and Analysis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Mexico Drug Contaminants Detection and Analysis Market Share by Country (2021-2032) Figure 28. Europe Drug Contaminants Detection and Analysis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Drug Contaminants Detection and Analysis Market Share by Country (2021-2032) Figure 30. Germany Drug Contaminants Detection and Analysis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. France Drug Contaminants Detection and Analysis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. U.K. Drug Contaminants Detection and Analysis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Italy Drug Contaminants Detection and Analysis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Spain Drug Contaminants Detection and Analysis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Russia Drug Contaminants Detection and Analysis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Netherlands Drug Contaminants Detection and Analysis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Nordic Countries Drug Contaminants Detection and Analysis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Drug Contaminants Detection and Analysis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Drug Contaminants Detection and Analysis Market Share by Country (2021-2032) Figure 40. China Drug Contaminants Detection and Analysis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. Japan Drug Contaminants Detection and Analysis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. South Korea Drug Contaminants Detection and Analysis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. India Drug Contaminants Detection and Analysis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 44. India Drug Contaminants Detection and Analysis Market Share by Country (2021-2032) Figure 45. Australia Drug Contaminants Detection and Analysis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. China Taiwan Drug Contaminants Detection and Analysis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. Southeast Asia Drug Contaminants Detection and Analysis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 48. South America Drug Contaminants Detection and Analysis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 49. South America Drug Contaminants Detection and Analysis Market Share by Country (2021-2032) Figure 50. Brazil Drug Contaminants Detection and Analysis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. Argentina Drug Contaminants Detection and Analysis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Chile Drug Contaminants Detection and Analysis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. Colombia Drug Contaminants Detection and Analysis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 54. Peru Drug Contaminants Detection and Analysis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 55. Eurofins Scientific (Luxembourg) Revenue Growth Rate in Drug Contaminants Detection and Analysis Business (2021-2026) Figure 56. SGS (Switzerland) Revenue Growth Rate in Drug Contaminants Detection and Analysis Business (2021-2026) Figure 57. Intertek (UK) Revenue Growth Rate in Drug Contaminants Detection and Analysis Business (2021-2026) Figure 58. Thermo Fisher Scientific (USA) Revenue Growth Rate in Drug Contaminants Detection and Analysis Business (2021-2026) Figure 59. Charles River Laboratories (USA) Revenue Growth Rate in Drug Contaminants Detection and Analysis Business (2021-2026) Figure 60. Labcorp Biopharma (USA) Revenue Growth Rate in Drug Contaminants Detection and Analysis Business (2021-2026) Figure 61. WuXi STA / WuXi AppTec (China) Revenue Growth Rate in Drug Contaminants Detection and Analysis Business (2021-2026) Figure 62. Cambrex (USA) Revenue Growth Rate in Drug Contaminants Detection and Analysis Business (2021-2026) Figure 63. Pharmaron (China) Revenue Growth Rate in Drug Contaminants Detection and Analysis Business (2021-2026) Figure 64. Piramal Pharma Solutions (India) Revenue Growth Rate in Drug Contaminants Detection and Analysis Business (2021-2026) Figure 65. Syngene (India) Revenue Growth Rate in Drug Contaminants Detection and Analysis Business (2021-2026) Figure 66. Recipharm (Sweden) Revenue Growth Rate in Drug Contaminants Detection and Analysis Business (2021-2026) Figure 67. Almac Sciences (UK) Revenue Growth Rate in Drug Contaminants Detection and Analysis Business (2021-2026) Figure 68. MedPharm (UK) Revenue Growth Rate in Drug Contaminants Detection and Analysis Business (2021-2026) Figure 69. CMIC (Japan) Revenue Growth Rate in Drug Contaminants Detection and Analysis Business (2021-2026) Figure 70. Aenova (Germany) Revenue Growth Rate in Drug Contaminants Detection and Analysis Business (2021-2026) Figure 71. Sterling Pharma Solutions (UK) Revenue Growth Rate in Drug Contaminants Detection and Analysis Business (2021-2026) Figure 72. Curia (USA) Revenue Growth Rate in Drug Contaminants Detection and Analysis Business (2021-2026) Figure 73. Ardena (Belgium) Revenue Growth Rate in Drug Contaminants Detection and Analysis Business (2021-2026) Figure 74. Hovione (Portugal) Revenue Growth Rate in Drug Contaminants Detection and Analysis Business (2021-2026) Figure 75. Delpharm (France) Revenue Growth Rate in Drug Contaminants Detection and Analysis Business (2021-2026) Figure 76. AGC Biologics (USA) Revenue Growth Rate in Drug Contaminants Detection and Analysis Business (2021-2026) Figure 77. FUJIFILM Biotechnologies (Japan) Revenue Growth Rate in Drug Contaminants Detection and Analysis Business (2021-2026) Figure 78. KBI Biopharma (USA) Revenue Growth Rate in Drug Contaminants Detection and Analysis Business (2021-2026) Figure 79. Rentschler Biopharma (Germany) Revenue Growth Rate in Drug Contaminants Detection and Analysis Business (2021-2026) Figure 80. Ajinomoto Bio-Pharma Services (Japan) Revenue Growth Rate in Drug Contaminants Detection and Analysis Business (2021-2026) Figure 81. Bora Pharmaceuticals (Taiwan, China) Revenue Growth Rate in Drug Contaminants Detection and Analysis Business (2021-2026) Figure 82. Kindeva (USA) Revenue Growth Rate in Drug Contaminants Detection and Analysis Business (2021-2026) Figure 83. CordenPharma (Switzerland) Revenue Growth Rate in Drug Contaminants Detection and Analysis Business (2021-2026) Figure 84. RSSL (UK) Revenue Growth Rate in Drug Contaminants Detection and Analysis Business (2021-2026) Figure 85. Tentamus (Germany) Revenue Growth Rate in Drug Contaminants Detection and Analysis Business (2021-2026) Figure 86. Element Materials Technology (UK) Revenue Growth Rate in Drug Contaminants Detection and Analysis Business (2021-2026) Figure 87. Nucro-Technics (Canada) Revenue Growth Rate in Drug Contaminants Detection and Analysis Business (2021-2026) Figure 88. ALS (Australia) Revenue Growth Rate in Drug Contaminants Detection and Analysis Business (2021-2026) Figure 89. Aizant (India) Revenue Growth Rate in Drug Contaminants Detection and Analysis Business (2021-2026) Figure 90. Wickham Laboratories (UK) Revenue Growth Rate in Drug Contaminants Detection and Analysis Business (2021-2026) Figure 91. Toxikon (USA) Revenue Growth Rate in Drug Contaminants Detection and Analysis Business (2021-2026) Figure 92. Evotec (Germany) Revenue Growth Rate in Drug Contaminants Detection and Analysis Business (2021-2026)

Scope & coverage.

Types
  • Organic Pollutant Detection Products
  • Inorganic Pollutant Detection Products
  • Others
Applications
  • Chemical Pharmaceutical Industry
  • Biopharmaceutical Industry
  • Traditional Chinese Medicine and Natural Medicine Industry
  • Others
Companies covered
  • Eurofins Scientific (Luxembourg)
  • SGS (Switzerland)
  • Intertek (UK)
  • Thermo Fisher Scientific (USA)
  • Charles River Laboratories (USA)
  • Labcorp Biopharma (USA)
  • WuXi STA / WuXi AppTec (China)
  • Cambrex (USA)
  • Pharmaron (China)
  • Piramal Pharma Solutions (India)
  • Syngene (India)
  • Recipharm (Sweden)
  • Almac Sciences (UK)
  • MedPharm (UK)
  • CMIC (Japan)
  • Aenova (Germany)
  • Sterling Pharma Solutions (UK)
  • Curia (USA)
  • Ardena (Belgium)
  • Hovione (Portugal)
  • Delpharm (France)
  • AGC Biologics (USA)
  • FUJIFILM Biotechnologies (Japan)
  • KBI Biopharma (USA)
  • Rentschler Biopharma (Germany)
  • Ajinomoto Bio-Pharma Services (Japan)
  • Bora Pharmaceuticals (Taiwan, China)
  • Kindeva (USA)
  • CordenPharma (Switzerland)
  • RSSL (UK)
  • Tentamus (Germany)
  • Element Materials Technology (UK)
  • Nucro-Technics (Canada)
  • ALS (Australia)
  • Aizant (India)
  • Wickham Laboratories (UK)
  • Toxikon (USA)
  • Evotec (Germany)

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Drug Contaminants Detection and Analysis by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 Organic Pollutant Detection Products
  5. 2.2.3 Inorganic Pollutant Detection Products
  6. 2.2.4 Others
  7. 2.3 Drug Contaminants Detection and Analysis by Application
  8. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  9. 2.3.2 Chemical Pharmaceutical Industry
  10. 2.3.3 Biopharmaceutical Industry
  11. 2.3.4 Traditional Chinese Medicine and Natural Medicine Industry
  12. 2.3.5 Others
  13. 2.4 Assumptions and Limitations
3 Drug Contaminants Detection and Analysis Breakdown Data by Type
  1. 3.1 Global Drug Contaminants Detection and Analysis Historic Market Size by Type (2021-2026)
  2. 3.2 Global Drug Contaminants Detection and Analysis Forecasted Market Size by Type (2027-2032)
4 Drug Contaminants Detection and Analysis Breakdown Data by Application
  1. 4.1 Global Drug Contaminants Detection and Analysis Historic Market Size by Application (2021-2026)
  2. 4.2 Global Drug Contaminants Detection and Analysis Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Drug Contaminants Detection and Analysis Market Perspective (2021-2032)
  2. 5.2 Global Drug Contaminants Detection and Analysis Growth Trends by Region
  3. 5.2.1 Global Drug Contaminants Detection and Analysis Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Drug Contaminants Detection and Analysis Historic Market Size by Region (2021-2026)
  5. 5.2.3 Drug Contaminants Detection and Analysis Forecasted Market Size by Region (2027-2032)
  6. 5.3 Drug Contaminants Detection and Analysis Market Dynamics
  7. 5.3.1 Drug Contaminants Detection and Analysis Industry Trends
  8. 5.3.2 Drug Contaminants Detection and Analysis Market Drivers
  9. 5.3.3 Drug Contaminants Detection and Analysis Market Challenges
  10. 5.3.4 Drug Contaminants Detection and Analysis Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Drug Contaminants Detection and Analysis Players by Revenue
  2. 6.1.1 Global Top Drug Contaminants Detection and Analysis Players by Revenue (2021-2026)
  3. 6.1.2 Global Drug Contaminants Detection and Analysis Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Drug Contaminants Detection and Analysis Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Drug Contaminants Detection and Analysis Head Office and Area Served
  6. 6.4 Global Drug Contaminants Detection and Analysis Players, Product Type & Application
  7. 6.5 Global Drug Contaminants Detection and Analysis Manufacturers Established Date
  8. 6.6 Global Drug Contaminants Detection and Analysis Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Drug Contaminants Detection and Analysis Market Size (2021-2032)
  2. 7.2 North America Drug Contaminants Detection and Analysis Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Drug Contaminants Detection and Analysis Market Size by Country (2021-2026)
  4. 7.4 North America Drug Contaminants Detection and Analysis Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Drug Contaminants Detection and Analysis Market Size (2021-2032)
  2. 8.2 Europe Drug Contaminants Detection and Analysis Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Drug Contaminants Detection and Analysis Market Size by Country (2021-2026)
  4. 8.4 Europe Drug Contaminants Detection and Analysis Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Drug Contaminants Detection and Analysis Market Size (2021-2032)
  2. 9.2 Asia-Pacific Drug Contaminants Detection and Analysis Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Drug Contaminants Detection and Analysis Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Drug Contaminants Detection and Analysis Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Drug Contaminants Detection and Analysis Market Size (2021-2032)
  2. 10.2 South America Drug Contaminants Detection and Analysis Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Drug Contaminants Detection and Analysis Market Size by Country (2021-2026)
  4. 10.4 South America Drug Contaminants Detection and Analysis Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Drug Contaminants Detection and Analysis Market Size (2021-2032)
  2. 11.2 Middle East & Africa Drug Contaminants Detection and Analysis Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Drug Contaminants Detection and Analysis Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Drug Contaminants Detection and Analysis Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 Eurofins Scientific (Luxembourg)
  2. 12.1.1 Eurofins Scientific (Luxembourg) Company Information
  3. 12.1.2 Eurofins Scientific (Luxembourg) Business Overview
  4. 12.1.3 Eurofins Scientific (Luxembourg) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026)
  5. 12.1.4 Eurofins Scientific (Luxembourg) Drug Contaminants Detection and Analysis Product Portfolio
  6. 12.1.5 Eurofins Scientific (Luxembourg) Recent Developments
  7. 12.2 SGS (Switzerland)
  8. 12.2.1 SGS (Switzerland) Company Information
  9. 12.2.2 SGS (Switzerland) Business Overview
  10. 12.2.3 SGS (Switzerland) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026)
  11. 12.2.4 SGS (Switzerland) Drug Contaminants Detection and Analysis Product Portfolio
  12. 12.2.5 SGS (Switzerland) Recent Developments
  13. 12.3 Intertek (UK)
  14. 12.3.1 Intertek (UK) Company Information
  15. 12.3.2 Intertek (UK) Business Overview
  16. 12.3.3 Intertek (UK) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026)
  17. 12.3.4 Intertek (UK) Drug Contaminants Detection and Analysis Product Portfolio
  18. 12.3.5 Intertek (UK) Recent Developments
  19. 12.4 Thermo Fisher Scientific (USA)
  20. 12.4.1 Thermo Fisher Scientific (USA) Company Information
  21. 12.4.2 Thermo Fisher Scientific (USA) Business Overview
  22. 12.4.3 Thermo Fisher Scientific (USA) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026)
  23. 12.4.4 Thermo Fisher Scientific (USA) Drug Contaminants Detection and Analysis Product Portfolio
  24. 12.4.5 Thermo Fisher Scientific (USA) Recent Developments
  25. 12.5 Charles River Laboratories (USA)
  26. 12.5.1 Charles River Laboratories (USA) Company Information
  27. 12.5.2 Charles River Laboratories (USA) Business Overview
  28. 12.5.3 Charles River Laboratories (USA) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026)
  29. 12.5.4 Charles River Laboratories (USA) Drug Contaminants Detection and Analysis Product Portfolio
  30. 12.5.5 Charles River Laboratories (USA) Recent Developments
  31. 12.6 Labcorp Biopharma (USA)
  32. 12.6.1 Labcorp Biopharma (USA) Company Information
  33. 12.6.2 Labcorp Biopharma (USA) Business Overview
  34. 12.6.3 Labcorp Biopharma (USA) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026)
  35. 12.6.4 Labcorp Biopharma (USA) Drug Contaminants Detection and Analysis Product Portfolio
  36. 12.6.5 Labcorp Biopharma (USA) Recent Developments
  37. 12.7 WuXi STA / WuXi AppTec (China)
  38. 12.7.1 WuXi STA / WuXi AppTec (China) Company Information
  39. 12.7.2 WuXi STA / WuXi AppTec (China) Business Overview
  40. 12.7.3 WuXi STA / WuXi AppTec (China) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026)
  41. 12.7.4 WuXi STA / WuXi AppTec (China) Drug Contaminants Detection and Analysis Product Portfolio
  42. 12.7.5 WuXi STA / WuXi AppTec (China) Recent Developments
  43. 12.8 Cambrex (USA)
  44. 12.8.1 Cambrex (USA) Company Information
  45. 12.8.2 Cambrex (USA) Business Overview
  46. 12.8.3 Cambrex (USA) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026)
  47. 12.8.4 Cambrex (USA) Drug Contaminants Detection and Analysis Product Portfolio
  48. 12.8.5 Cambrex (USA) Recent Developments
  49. 12.9 Pharmaron (China)
  50. 12.9.1 Pharmaron (China) Company Information
  51. 12.9.2 Pharmaron (China) Business Overview
  52. 12.9.3 Pharmaron (China) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026)
  53. 12.9.4 Pharmaron (China) Drug Contaminants Detection and Analysis Product Portfolio
  54. 12.9.5 Pharmaron (China) Recent Developments
  55. 12.10 Piramal Pharma Solutions (India)
  56. 12.10.1 Piramal Pharma Solutions (India) Company Information
  57. 12.10.2 Piramal Pharma Solutions (India) Business Overview
  58. 12.10.3 Piramal Pharma Solutions (India) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026)
  59. 12.10.4 Piramal Pharma Solutions (India) Drug Contaminants Detection and Analysis Product Portfolio
  60. 12.10.5 Piramal Pharma Solutions (India) Recent Developments
  61. 12.11 Syngene (India)
  62. 12.11.1 Syngene (India) Company Information
  63. 12.11.2 Syngene (India) Business Overview
  64. 12.11.3 Syngene (India) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026)
  65. 12.11.4 Syngene (India) Drug Contaminants Detection and Analysis Product Portfolio
  66. 12.11.5 Syngene (India) Recent Developments
  67. 12.12 Recipharm (Sweden)
  68. 12.12.1 Recipharm (Sweden) Company Information
  69. 12.12.2 Recipharm (Sweden) Business Overview
  70. 12.12.3 Recipharm (Sweden) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026)
  71. 12.12.4 Recipharm (Sweden) Drug Contaminants Detection and Analysis Product Portfolio
  72. 12.12.5 Recipharm (Sweden) Recent Developments
  73. 12.13 Almac Sciences (UK)
  74. 12.13.1 Almac Sciences (UK) Company Information
  75. 12.13.2 Almac Sciences (UK) Business Overview
  76. 12.13.3 Almac Sciences (UK) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026)
  77. 12.13.4 Almac Sciences (UK) Drug Contaminants Detection and Analysis Product Portfolio
  78. 12.13.5 Almac Sciences (UK) Recent Developments
  79. 12.14 MedPharm (UK)
  80. 12.14.1 MedPharm (UK) Company Information
  81. 12.14.2 MedPharm (UK) Business Overview
  82. 12.14.3 MedPharm (UK) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026)
  83. 12.14.4 MedPharm (UK) Drug Contaminants Detection and Analysis Product Portfolio
  84. 12.14.5 MedPharm (UK) Recent Developments
  85. 12.15 CMIC (Japan)
  86. 12.15.1 CMIC (Japan) Company Information
  87. 12.15.2 CMIC (Japan) Business Overview
  88. 12.15.3 CMIC (Japan) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026)
  89. 12.15.4 CMIC (Japan) Drug Contaminants Detection and Analysis Product Portfolio
  90. 12.15.5 CMIC (Japan) Recent Developments
  91. 12.16 Aenova (Germany)
  92. 12.16.1 Aenova (Germany) Company Information
  93. 12.16.2 Aenova (Germany) Business Overview
  94. 12.16.3 Aenova (Germany) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026)
  95. 12.16.4 Aenova (Germany) Drug Contaminants Detection and Analysis Product Portfolio
  96. 12.16.5 Aenova (Germany) Recent Developments
  97. 12.17 Sterling Pharma Solutions (UK)
  98. 12.17.1 Sterling Pharma Solutions (UK) Company Information
  99. 12.17.2 Sterling Pharma Solutions (UK) Business Overview
  100. 12.17.3 Sterling Pharma Solutions (UK) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026)
  101. 12.17.4 Sterling Pharma Solutions (UK) Drug Contaminants Detection and Analysis Product Portfolio
  102. 12.17.5 Sterling Pharma Solutions (UK) Recent Developments
  103. 12.18 Curia (USA)
  104. 12.18.1 Curia (USA) Company Information
  105. 12.18.2 Curia (USA) Business Overview
  106. 12.18.3 Curia (USA) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026)
  107. 12.18.4 Curia (USA) Drug Contaminants Detection and Analysis Product Portfolio
  108. 12.18.5 Curia (USA) Recent Developments
  109. 12.19 Ardena (Belgium)
  110. 12.19.1 Ardena (Belgium) Company Information
  111. 12.19.2 Ardena (Belgium) Business Overview
  112. 12.19.3 Ardena (Belgium) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026)
  113. 12.19.4 Ardena (Belgium) Drug Contaminants Detection and Analysis Product Portfolio
  114. 12.19.5 Ardena (Belgium) Recent Developments
  115. 12.20 Hovione (Portugal)
  116. 12.20.1 Hovione (Portugal) Company Information
  117. 12.20.2 Hovione (Portugal) Business Overview
  118. 12.20.3 Hovione (Portugal) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026)
  119. 12.20.4 Hovione (Portugal) Drug Contaminants Detection and Analysis Product Portfolio
  120. 12.20.5 Hovione (Portugal) Recent Developments
  121. 12.21 Delpharm (France)
  122. 12.21.1 Delpharm (France) Company Information
  123. 12.21.2 Delpharm (France) Business Overview
  124. 12.21.3 Delpharm (France) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026)
  125. 12.21.4 Delpharm (France) Drug Contaminants Detection and Analysis Product Portfolio
  126. 12.21.5 Delpharm (France) Recent Developments
  127. 12.22 AGC Biologics (USA)
  128. 12.22.1 AGC Biologics (USA) Company Information
  129. 12.22.2 AGC Biologics (USA) Business Overview
  130. 12.22.3 AGC Biologics (USA) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026)
  131. 12.22.4 AGC Biologics (USA) Drug Contaminants Detection and Analysis Product Portfolio
  132. 12.22.5 AGC Biologics (USA) Recent Developments
  133. 12.23 FUJIFILM Biotechnologies (Japan)
  134. 12.23.1 FUJIFILM Biotechnologies (Japan) Company Information
  135. 12.23.2 FUJIFILM Biotechnologies (Japan) Business Overview
  136. 12.23.3 FUJIFILM Biotechnologies (Japan) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026)
  137. 12.23.4 FUJIFILM Biotechnologies (Japan) Drug Contaminants Detection and Analysis Product Portfolio
  138. 12.23.5 FUJIFILM Biotechnologies (Japan) Recent Developments
  139. 12.24 KBI Biopharma (USA)
  140. 12.24.1 KBI Biopharma (USA) Company Information
  141. 12.24.2 KBI Biopharma (USA) Business Overview
  142. 12.24.3 KBI Biopharma (USA) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026)
  143. 12.24.4 KBI Biopharma (USA) Drug Contaminants Detection and Analysis Product Portfolio
  144. 12.24.5 KBI Biopharma (USA) Recent Developments
  145. 12.25 Rentschler Biopharma (Germany)
  146. 12.25.1 Rentschler Biopharma (Germany) Company Information
  147. 12.25.2 Rentschler Biopharma (Germany) Business Overview
  148. 12.25.3 Rentschler Biopharma (Germany) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026)
  149. 12.25.4 Rentschler Biopharma (Germany) Drug Contaminants Detection and Analysis Product Portfolio
  150. 12.25.5 Rentschler Biopharma (Germany) Recent Developments
  151. 12.26 Ajinomoto Bio-Pharma Services (Japan)
  152. 12.26.1 Ajinomoto Bio-Pharma Services (Japan) Company Information
  153. 12.26.2 Ajinomoto Bio-Pharma Services (Japan) Business Overview
  154. 12.26.3 Ajinomoto Bio-Pharma Services (Japan) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026)
  155. 12.26.4 Ajinomoto Bio-Pharma Services (Japan) Drug Contaminants Detection and Analysis Product Portfolio
  156. 12.26.5 Ajinomoto Bio-Pharma Services (Japan) Recent Developments
  157. 12.27 Bora Pharmaceuticals (Taiwan, China)
  158. 12.27.1 Bora Pharmaceuticals (Taiwan, China) Company Information
  159. 12.27.2 Bora Pharmaceuticals (Taiwan, China) Business Overview
  160. 12.27.3 Bora Pharmaceuticals (Taiwan, China) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026)
  161. 12.27.4 Bora Pharmaceuticals (Taiwan, China) Drug Contaminants Detection and Analysis Product Portfolio
  162. 12.27.5 Bora Pharmaceuticals (Taiwan, China) Recent Developments
  163. 12.28 Kindeva (USA)
  164. 12.28.1 Kindeva (USA) Company Information
  165. 12.28.2 Kindeva (USA) Business Overview
  166. 12.28.3 Kindeva (USA) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026)
  167. 12.28.4 Kindeva (USA) Drug Contaminants Detection and Analysis Product Portfolio
  168. 12.28.5 Kindeva (USA) Recent Developments
  169. 12.29 CordenPharma (Switzerland)
  170. 12.29.1 CordenPharma (Switzerland) Company Information
  171. 12.29.2 CordenPharma (Switzerland) Business Overview
  172. 12.29.3 CordenPharma (Switzerland) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026)
  173. 12.29.4 CordenPharma (Switzerland) Drug Contaminants Detection and Analysis Product Portfolio
  174. 12.29.5 CordenPharma (Switzerland) Recent Developments
  175. 12.30 RSSL (UK)
  176. 12.30.1 RSSL (UK) Company Information
  177. 12.30.2 RSSL (UK) Business Overview
  178. 12.30.3 RSSL (UK) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026)
  179. 12.30.4 RSSL (UK) Drug Contaminants Detection and Analysis Product Portfolio
  180. 12.30.5 RSSL (UK) Recent Developments
  181. 12.31 Tentamus (Germany)
  182. 12.31.1 Tentamus (Germany) Company Information
  183. 12.31.2 Tentamus (Germany) Business Overview
  184. 12.31.3 Tentamus (Germany) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026)
  185. 12.31.4 Tentamus (Germany) Drug Contaminants Detection and Analysis Product Portfolio
  186. 12.31.5 Tentamus (Germany) Recent Developments
  187. 12.32 Element Materials Technology (UK)
  188. 12.32.1 Element Materials Technology (UK) Company Information
  189. 12.32.2 Element Materials Technology (UK) Business Overview
  190. 12.32.3 Element Materials Technology (UK) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026)
  191. 12.32.4 Element Materials Technology (UK) Drug Contaminants Detection and Analysis Product Portfolio
  192. 12.32.5 Element Materials Technology (UK) Recent Developments
  193. 12.33 Nucro-Technics (Canada)
  194. 12.33.1 Nucro-Technics (Canada) Company Information
  195. 12.33.2 Nucro-Technics (Canada) Business Overview
  196. 12.33.3 Nucro-Technics (Canada) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026)
  197. 12.33.4 Nucro-Technics (Canada) Drug Contaminants Detection and Analysis Product Portfolio
  198. 12.33.5 Nucro-Technics (Canada) Recent Developments
  199. 12.34 ALS (Australia)
  200. 12.34.1 ALS (Australia) Company Information
  201. 12.34.2 ALS (Australia) Business Overview
  202. 12.34.3 ALS (Australia) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026)
  203. 12.34.4 ALS (Australia) Drug Contaminants Detection and Analysis Product Portfolio
  204. 12.34.5 ALS (Australia) Recent Developments
  205. 12.35 Aizant (India)
  206. 12.35.1 Aizant (India) Company Information
  207. 12.35.2 Aizant (India) Business Overview
  208. 12.35.3 Aizant (India) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026)
  209. 12.35.4 Aizant (India) Drug Contaminants Detection and Analysis Product Portfolio
  210. 12.35.5 Aizant (India) Recent Developments
  211. 12.36 Wickham Laboratories (UK)
  212. 12.36.1 Wickham Laboratories (UK) Company Information
  213. 12.36.2 Wickham Laboratories (UK) Business Overview
  214. 12.36.3 Wickham Laboratories (UK) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026)
  215. 12.36.4 Wickham Laboratories (UK) Drug Contaminants Detection and Analysis Product Portfolio
  216. 12.36.5 Wickham Laboratories (UK) Recent Developments
  217. 12.37 Toxikon (USA)
  218. 12.37.1 Toxikon (USA) Company Information
  219. 12.37.2 Toxikon (USA) Business Overview
  220. 12.37.3 Toxikon (USA) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026)
  221. 12.37.4 Toxikon (USA) Drug Contaminants Detection and Analysis Product Portfolio
  222. 12.37.5 Toxikon (USA) Recent Developments
  223. 12.38 Evotec (Germany)
  224. 12.38.1 Evotec (Germany) Company Information
  225. 12.38.2 Evotec (Germany) Business Overview
  226. 12.38.3 Evotec (Germany) Revenue in Drug Contaminants Detection and Analysis Business (2021-2026)
  227. 12.38.4 Evotec (Germany) Drug Contaminants Detection and Analysis Product Portfolio
  228. 12.38.5 Evotec (Germany) Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst